Ragunath Singaravelu has not added Biography.
If you are Ragunath Singaravelu and would like to personalize this page please email our Author Liaison for assistance.
MicroRNAs regulate the immunometabolic response to viral infection in the liver.
Nature chemical biology Dec, 2015 | Pubmed ID: 26479438
Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses.
Stem cells (Dayton, Ohio) 06, 2019 | Pubmed ID: 30875126
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy.
Molecular therapy oncolytics Sep, 2019 | Pubmed ID: 31428674
Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity.
Expert opinion on biological therapy 09, 2020 | Pubmed ID: 32297534
Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis.
Cancers Jul, 2020 | Pubmed ID: 32722184
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.
Membranes Aug, 2020 | Pubmed ID: 32872641
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
Molecular therapy : the journal of the American Society of Gene Therapy Jun, 2021 | Pubmed ID: 33578036
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
International journal of molecular sciences Feb, 2021 | Pubmed ID: 33668756
SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition.
Biosensors & bioelectronics May, 2021 | Pubmed ID: 33706157
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion.
Nanomaterials (Basel, Switzerland) Mar, 2021 | Pubmed ID: 33809836
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。